NASDAQ:LFVN

LifeVantage (LFVN) Stock Forecast, Price & News

$6.51

-0.19 (-2.84%)

(As of 12:33 PM ET)

Compare

Today's Range: $6.44
▼
$6.68
50-Day Range: $4.72
▼
$7.51
52-Week Range: $3.04
▼
$7.89

Volume: 13,865 shs
Average Volume: 40,285 shs
Market Capitalization: $82.74 million

P/E Ratio: 32.55
Dividend Yield: 2.15%
Price Target: N/A

LifeVantage MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.08% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.50
Upright™ Environmental Score
News Sentiment: 1.13
Based on 5 Articles This Week
Insider Trading: Acquiring Shares
$175,227 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

230th out of 976 stocks

Pharmaceutical Preparations Industry

85th out of 447 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for LifeVantage.

5.0

Short Interest

Percentage of Shares Shorted
1.08% of the float of LifeVantage has been sold short.
Short Interest Ratio / Days to Cover
LifeVantage has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in LifeVantage has recently decreased by 23.09%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
LifeVantage pays a meaningful dividend of 2.17%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
LifeVantage has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of LifeVantage is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%.

2.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
LifeVantage has received a 20.78% net impact score from Upright. LifeVantage seems to create the most significant positive value in categories "Taxes", "Physical diseases", and "Jobs". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Plant-based fatty acid supplements", "Probiotics", and "Herbal dietary supplements" products. See details.
Environmental Sustainability
The Environmental Impact score for LifeVantage is -1.50.

3.4

News and Social Media Coverage

News Sentiment
LifeVantage has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for LifeVantage this week, compared to 1 article on an average week.
MarketBeat Follows
5 people have added LifeVantage to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LifeVantage insiders have bought more of their company's stock than they have sold. Specifically, they have bought $175,227.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 6.76% of the stock of LifeVantage is held by insiders.
Percentage Held by Institutions
Only 35.66% of the stock of LifeVantage is held by institutions.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of LifeVantage is 32.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.44.
Price to Earnings Ratio vs. Sector
The P/E ratio of LifeVantage is 32.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 108.84.
Price to Book Value per Share Ratio
LifeVantage has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About LifeVantage (NASDAQ:LFVN) Stock

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LFVN Price History

30 days | 90 days | 365 days | Advanced Chart

LFVN Stock News Headlines

September 26, 2023 | msn.com

LifeVantage gains as investor files definitive proxy seeking three board seats

September 26, 2023 | finance.yahoo.com

LifeVantage Issues Letter to Shareholders Urging Support of Its Directors Ahead of Nov. 6 Vote

October 3, 2023 | Goldco (Ad)

Ben Stein FREE Report: How Americans Are RUINING Retirement

There’s a new report just out from famed author, actor and economist Ben Stein. In this FREE REPORT, Ben reveals the lessons he learned from his late father and economist Herbert Stein. Discover how everyday Americans are currently ruining their retirements, and how YOU can save yours!

September 26, 2023 | finance.yahoo.com

The Radoff-Sudbury Group Files Definitive Proxy and Issues Letter to LifeVantage Corporation Stockholders

September 25, 2023 | finance.yahoo.com

LifeVantage Files Definitive Proxy Statement

September 8, 2023 | finance.yahoo.com

LifeVantage to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

August 31, 2023 | finance.yahoo.com

LifeVantage Adopts Limited Duration Stockholder Rights Plan

August 30, 2023 | finance.yahoo.com

LifeVantage Corporation's (NASDAQ:LFVN) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

October 3, 2023 | Goldco (Ad)

Ben Stein FREE Report: How Americans Are RUINING Retirement

August 29, 2023 | benzinga.com

Dow Surges 250 Points; Smucker Earnings Top Estimates

August 29, 2023 | benzinga.com

Nasdaq Jumps Over 200 Points; US Job Openings Tumble In July

August 29, 2023 | marketwatch.com

LifeVantage Shares Touch 52-Week High After Swing to 4Q Gain

August 29, 2023 | uk.finance.yahoo.com

Q4 2023 LifeVantage Corp Earnings Call

August 29, 2023 | finance.yahoo.com

LifeVantage Corporation (NASDAQ:LFVN) Q4 2023 Earnings Call Transcript

August 29, 2023 | finanznachrichten.de

LifeVantage Corporation: LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2023

August 28, 2023 | msn.com

Dow futures tick higher, HEICO slips 5.9% after-hours

August 28, 2023 | markets.businessinsider.com

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2023

August 28, 2023 | msn.com

Monday’s Wall Street Highlights: Jabil, Xpeng, 3M, Hostess Brands, and more

August 14, 2023 | finance.yahoo.com

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2023 Results on August 28, 2023

July 22, 2023 | fool.com

LifeVantage (NASDAQ: LFVN)

July 17, 2023 | stocknews.com

3 Top Stocks to Buy in the #1 Ranked Industry

July 12, 2023 | finance.yahoo.com

LifeVantage to Ring the Nasdaq Stock Market Closing Bell

July 11, 2023 | finance.yahoo.com

Returns On Capital Signal Tricky Times Ahead For LifeVantage (NASDAQ:LFVN)

June 16, 2023 | finanznachrichten.de

LifeVantage Corporation: TrueScience Liquid Collagen Celebrates First Year with Continued Growth, Multiple Awards

June 15, 2023 | finance.yahoo.com

TrueScience® Liquid Collagen Celebrates First Year with Continued Growth, Multiple Awards

June 13, 2023 | finance.yahoo.com

LifeVantage Extends Stock Repurchase Program

June 7, 2023 | finance.yahoo.com

Several Insiders Invested In LifeVantage Flagging Positive News

See More Headlines

Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Company Calendar

Last Earnings: 8/28/2023
Ex-Dividend for 9/22 Dividend: 9/07/2023
Dividend Payable: 9/22/2023
Today: 10/03/2023
Next Earnings (Estimated): 11/01/2023
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LFVN
CUSIP: N/A
CIK: 849146
Web: www.lifevantage.com
Phone: (801) 432-9000
Fax: 801-880-0699
Employees: 248
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.20
Trailing P/E Ratio: 33.50
Forward P/E Ratio: 11.75
P/E Growth: N/A
Net Income: $2.54 million
Net Margins: 1.19%
Pretax Margin: 1.87%
Return on Equity: 9.27%
Return on Assets: 4.55%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.26
Quick Ratio: 1.44

Sales & Book Value

Annual Sales: $213.40 million
Price / Sales: 0.40
Cash Flow: $0.54 per share
Price / Cash Flow: 12.44
Book Value: $2.71 per share
Price / Book: 2.47

Miscellaneous

Outstanding Shares: 12,710,000
Free Float: 11,848,000
Market Cap: $85.16 million
Optionable: Optionable
Beta: 0.86

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Steven R. Fife (Age 62)
Pres, CEO & Director
Comp: $882.36k

Mr. Carl A. Aure (Age 50)
Chief Financial Officer
Comp: $534.78k

Ms. Julie Boyster (Age 38)
Chief Marketing Officer
Comp: $434.62k

Mr. Eric E. Marchant
VP of Compliance

Ms. Alissa Neufeld (Age 44)
Gen. Counsel & Corp. Sec.

Chris Taylor
Director of Communications

Ms. Kristen Cunningham (Age 39)
Chief Sales Officer

Ms. Michelle Oborn-Virchow (Age 43)
Chief People Officer

Ms. Calli Mott
Sr. VP of Distributor Experience

Mr. Eiichi Shiokawa
Managing Director - Japan

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LFVN Stock - Frequently Asked Questions

How have LFVN shares performed in 2023?: LifeVantage's stock was trading at $3.72 at the start of the year. Since then, LFVN stock has increased by 80.1% and is now trading at $6.70.
View the best growth stocks for 2023 here.
Are investors shorting LifeVantage?: LifeVantage saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 110,600 shares, a drop of 23.1% from the August 31st total of 143,800 shares. Based on an average daily trading volume, of 73,500 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.1% of the shares of the stock are sold short.
View LifeVantage's Short Interest.
When is LifeVantage's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our LFVN earnings forecast.
How were LifeVantage's earnings last quarter?: LifeVantage Co. (NASDAQ:LFVN) posted its quarterly earnings data on Monday, August, 28th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by $0.03. The firm earned $54.22 million during the quarter. LifeVantage had a trailing twelve-month return on equity of 9.27% and a net margin of 1.19%. During the same quarter in the previous year, the firm earned $0.01 earnings per share.
How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?: LifeVantage declared a None dividend on Monday, August 28th. Shareholders of record on Friday, September 8th will be given a dividend of $0.435 per share on Friday, September 22nd. This represents a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for LFVN.
Is LifeVantage a good dividend stock?: LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.17%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LFVN.
What guidance has LifeVantage issued on next quarter's earnings?: LifeVantage updated its FY 2024 earnings guidance on Monday, August, 28th. The company provided earnings per share (EPS) guidance of $0.52-$0.62 for the period. The company issued revenue guidance of $216.00 million-$226.00 million.

What is Darren Jensen's approval rating as LifeVantage's CEO?: 5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.
What other stocks do shareholders of LifeVantage own?: Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).
What is LifeVantage's stock symbol?: LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."
How do I buy shares of LifeVantage?: Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LifeVantage's stock price today?: One share of LFVN stock can currently be purchased for approximately $6.70.
How much money does LifeVantage make?: LifeVantage (NASDAQ:LFVN) has a market capitalization of $85.16 million and generates $213.40 million in revenue each year. The company earns $2.54 million in net income (profit) each year or $0.20 on an earnings per share basis.
How many employees does LifeVantage have?: The company employs 248 workers across the globe.
How can I contact LifeVantage?: LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699.

This page (NASDAQ:LFVN) was last updated on 10/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial